Deutsche Bank Raises BrightSpring Health Services (BTSG) PT to $30 Following Strong Q2 Growth

BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best IPO stocks to buy and hold for 3 years. On September 9, Deutsche Bank analyst Pito Chickering raised the firm’s price target on BrightSpring Health to $30 from $25, while maintaining a Buy rating on the shares.

Earlier in August, BrightSpring Health Services also released its Q2 2025 earnings, where the company’s total revenue grew by 29% year-over-year to $3.1 billion, primarily due to its Pharmacy Solutions segment. This segment in particular saw a 32% increase in revenue and reached $2.8 billion. Within Pharmacy Solutions, infusion and specialty revenue surged by 39% to $2.2 billion, and specialty scripts grew by 38%.

The Provider Services segment also contributed to the growth with an 11% increase in revenue to $358 million. This segment’s growth was fueled by home healthcare revenue, which rose 17% to $185 million, along with increases in rehab revenue by 9% to $73 million and personal care revenue by 4% to $100 million. Overall, the company’s gross profit increased by 20% year-over-year to $375 million.

BrightSpring Health Services Inc. (NASDAQ:BTSG) is a home and community-based healthcare services platform in the US. It has 2 segments: Pharmacy Solutions and Provider Services.

While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.